Pharmacoeconomic Aspects of Different Inhibitors of Tyrosine Kinase in First-Line Therapy of Patients with Advanced Non-Small Cell Lung Cancer with A Mutation in Epidermal Growth Factor Receptor (EGFR) Gene
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2139
https://www.valueinhealthjournal.com/article/S1098-3015(16)33505-7/fulltext
Title :
Pharmacoeconomic Aspects of Different Inhibitors of Tyrosine Kinase in First-Line Therapy of Patients with Advanced Non-Small Cell Lung Cancer with A Mutation in Epidermal Growth Factor Receptor (EGFR) Gene
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33505-7&doi=10.1016/j.jval.2016.09.2139
First page :
A720
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2027